News
TipRanks on MSN13h
Ultragenyx initiates rolling submission of BLA to U.S. FDA for DTX401
Pharmaceutical announced the initiation of a rolling submission of a Biologics License Application, BLA, to the U.S. Food and ...
TipRanks on MSN17h
Expand Energy downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded Expand Energy (EXE) to Neutral from Buy with a price target of $98, down from $125. The firm downgraded a host of gas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback